Characteristics | All Subjects (N = 66) | Number of RCA During Follow-up | P Value | |||
---|---|---|---|---|---|---|
≤10 (N = 16) | 11–49 (N = 16) | 50–239 (N = 17) | ≥240 (N = 17) | |||
Age (years) | 56.3 ± 12.2 | 61.1 ± 9.1 | 56.3 ± 12.0 | 54.1 ± 13.0 | 54.1 ± 13.7 | 0.31 |
Female | 20/66 (30.3%) | 5/16 (31.3%) | 5/16 (31.3%) | 5/17 (29.4%) | 5/17 (29.4%) | > 0.99 |
Race | 0.15 | |||||
Asian | 23/66 (34.8%) | 9/16 (56.3%) | 7/16 (43.8%) | 4/17 (23.5%) | 3/17 (17.6%) | |
Black | 35/66 (53.0%) | 7/16 (43.8%) | 8/16 (50.0%) | 11/17 (64.7%) | 9/17 (52.9%) | |
Other | 1/66 (1.5%) | 0/16 (0.0%) | 0/16 (0.0%) | 0/17 (0.0%) | 1/17 (5.9%) | |
White | 7/66 (10.6%) | 0/16 (0.0%) | 1/16 (6.3%) | 2/17 (11.8%) | 4/17 (23.5%) | |
Systolic blood pressure | 140.8 ± 23.4 | 140.9 ± 19.9 | 145.9 ± 23.9 | 135.8 ± 23.0 | 140.9 ± 27.0 | 0.68 |
Diastolic blood pressure | 80 (70, 84) | 76 (59, 80) | 80 (71, 81) | 80 (64, 85) | 84 (74, 90) | 0.14 |
Weight (kg) | 81.7 (68.2, 95.2) | 78.1 (68.8, 91.0) | 84.8 (61.7, 89.5) | 80.4 (68.9, 119.0) | 83.7 (75.8, 108.2) | 0.59 |
BMI ≥ 40 | 6/66 (9.1%) | 1/16 (6.3%) | 1/16 (6.3%) | 2/17 (11.8%) | 2/17 (11.8%) | > 0.99 |
Cause of ESRD | ||||||
Diabetes | 28/66 (42.4%) | 11/16 (68.8%) | 6/16 (37.5%) | 4/17 (23.5%) | 7/17 (41.2%) | 0.14 |
Glomerulonephritis | 6/66 (9.1%) | 0/16 (0.0%) | 1/16 (6.3%) | 4/17 (23.5%) | 1/17 (5.9%) | |
Hypertension | 25/66 (37.9%) | 5/16 (31.3%) | 6/16 (37.5%) | 8/17 (47.1%) | 6/17 (35.3%) | |
Other | 10.6% (7/66) | 0/16 (0.0%) | 3/16 (18.8%) | 1/17 (5.9%) | 3/17 (17.6%) | |
ESRD Vintage (years) | 2.4 (1.2, 5.3) (N = 65) | 2.2 (1.2, 4.3) (N = 16) | 2.9 (1.5, 5.5) (N = 15) | 2.5 (1.2, 5.7) (N = 17) | 2.5 (0.7, 5.3) (N = 17) | 0.78 |
Prior kidney transplant | 9/66 (13.6%) | 2/16 (12.5%) | 4/17 (23.5%) | 3/17 (17.6%) | 2/16 (12.5%) | 0.25 |
Previous peritoneal dialysis | 7/66 (10.6%) | 1/16 (6.3%) | 2/16 (12.5%) | 2/17 (11.8%) | 2/17 (11.8%) | > 0.99 |
Vascular Access | ||||||
AV Fistula | 45/65 (69.2%) | 12/16 (75.0%) | 12/16 (75.0%) | 11/17 (64.7%) | 10/16 (62.5%) | 0.87 |
AV Graft | 17/65 (26.2%) | 3/16 (18.8%) | 3/16 (18.8%) | 5/17 (29.4%) | 6/16 (37.5%) | |
Catheter | 3/65 (4.6%) | 1/16 (6.3%) | 1/16 (6.3%) | 1/17 (5.9%) | 0/16 (0.0%) | |
Diabetes | 42/66 (63.6%) | 13/16 (81.3%) | 10/16 (62.5%) | 8/17 (47.1%) | 11/17 (64.7%) | 0.25 |
Hyperlipidemia | 40/66 (60.6%) | 9/16 (56.3%) | 8/16 (50.0%) | 11/17 (64.7%) | 12/17 (70.6%) | 0.66 |
Hypertension | 56/66 (84.8%) | 15/16 (93.8%) | 13/16 (81.3%) | 15/17 (88.2%) | 13/17 (76.5%) | 0.61 |
Ischemic heart disease | 32/66 (48.5%) | 10/16 (62.5%) | 8/16 (50.0%) | 8/17 (47.1%) | 6/17 (35.3%) | 0.51 |
History of MI | 6/66 (9.1%) | 1/16 (6.3%) | 2/16 (12.5%) | 1/17 (5.9%) | 2/17 (11.8%) | 0.95 |
Congestive heart failure | 17/66 (25.8%) | 3/16 (18.8%) | 3/16 (18.8%) | 4/17 (23.5%) | 7/17 (41.2%) | 0.46 |
Coronary artery bypass surgery | 9/66 (13.6%) | 4/16 (25.0%) | 3/16 (18.8%) | 1/17 (5.9%) | 1/17 (5.9%) | 0.32 |
Arrhythmia | 21/66 (31.8%) | 3/16 (18.8%) | 4/16 (25.0%) | 7/17 (41.2%) | 7/17 (41.2%) | 0.42 |
Smoking | 0.45 | |||||
Current | 5/66 (7.6%) | 0/16 (0.0%) | 1/16 (6.3%) | 3/17 (17.6%) | 1/17 (5.9%) | |
Never | 46/66 (69.7%) | 13/16 (81.3%) | 9/16 (56.3%) | 11/17 (64.7%) | 13/17 (76.5%) | |
Past | 15/66 (22.7%) | 3/16 (18.8%) | 6/16 (37.5%) | 3/17 (17.6%) | 3/17 (17.6%) | |
LVEF | 55.0 (55.0, 60.0) (N = 65) | 55.0 (55.0, 60.0) (N = 15) | 57.8 (55.0, 63.5) (N = 16) | 60.0 (55.0, 63.0) (N = 17) | 55.0 (55.0, 60.0) (N = 17) | 0.65 |